BioCardia, Inc.
BCDANASDAQHealthcare● Active
$0.92
$-0.11(-10.68%)
Market Cap$5334911
P/E Ratio—
52W High$2.45
52W Low$0.84
BioCardia, Inc. (BCDA) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · BCDA · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Cost of Revenue | $0.00B | $0.00B | $0.01B | $0.01B | $0.00B |
| Gross Profit | ($0.00B) | ($0.00B) | ($0.01B) | ($0.01B) | $0.00B |
| Gross Margin %(computed) | — | — | — | -553.40% | 36.95% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.01B | $0.01B | $0.01B |
| G&A Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | $0.01B | $0.00B | $0.00B | $0.00B | $0.01B |
| Operating Income | ($0.01B) | ($0.01B) | ($0.01B) | ($0.01B) | ($0.01B) |
| Operating Margin %(computed) | — | — | — | -880.25% | — |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.01B) | ($0.01B) | ($0.01B) | ($0.01B) | ($0.01B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | ($0.01B) | ($0.01B) | ($0.01B) | ($0.01B) | ($0.01B) |
| Net Margin %(computed) | — | — | — | -880.70% | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-1.23 | $-2.90 | $-8.19 | $-10.05 | $-11.19 |
| Wtd Avg Shares | 0.01B | 0.00B | 0.00B | 0.00B | 0.00B |
| EBITDA | ($0.01B) | ($0.01B) | ($0.01B) | ($0.01B) | ($0.01B) |
| EBITDA Margin %(computed) | — | — | — | -874.19% | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more BioCardia, Inc. data
About BioCardia, Inc. (BCDA) Income Statement
BioCardia, Inc. (BCDA) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, BCDA reported revenue of $0.00B, gross profit of ($0.00B) (gross margin —), and net income of ($0.01B) — a net profit margin of —.
Frequently asked questions
BCDA · 4 questionsBioCardia, Inc. (BCDA) reported revenue of $0.00B for 2025, down 100.0% year-over-year.
BCDA revenueBCDA salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08